Max Healthcare, Deepak Fertilisers, and Blue Star were among the top winners in the Nifty 500 universe last week, with stocks rallying up to 14.14%, outperforming the Nifty 500, which gained nearly 1.5%, and the benchmark Nifty 50, which rose around 2.5% during the same period. (Data Source: ACE Equity)

Max Healthcare Institute

The healthcare sector stock topped the list of weekly gainers, rising 14.14% over the last one week.

Deepak Fertilisers and Petrochemicals Corporation

The fertiliser and chemicals company ranked second, gaining 13.90% during the period.

Blue Star

The consumer durables and air-conditioning company ranked third, with its shares advancing 12.84% over the last one week.

Signature Global (India)

The real estate sector player ranked fourth, posting a gain of 12.11% during the period.

Aptus Value Housing Finance India

The housing finance company ranked fifth, with its shares rising 11.78% over the last one week.

Vijaya Diagnostic Centre

The healthcare diagnostics company ranked sixth, recording a weekly gain of 11.50%.

Indian Renewable Energy Development Agency

The renewable energy financing company ranked seventh, with its shares gaining 11.33% during the week.

Belrise Industries

The automotive components manufacturer ranked eighth, advancing 9.82% over the last one week.

IDFC First Bank

The private sector lender ranked ninth, with its shares rising 9.71% during the period.

IndusInd Bank

The private sector lender rounded out the list of 10 weekly gainers, posting a 9.69% rise over the last one week.

Disclosure: This article has been written by Kumar Gaurav, who is not a Sebi-registered Research Analyst or an Investment Adviser. Gaurav and their ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective Sebi-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here